Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Yoshihiro Shimodozono"'
Autor:
Akio Kawachi, Yusuke Sakamoto, Shunya Mouri, Mitsuaki Fukumori, Riku Kawano, Takaya Murakami, Junichiro Sonoda, Keiko Narumi, Yoshihiro Shimodozono, Kenji Etoh, Susumu Chiyotanda, Takashi Furuie, Keizo Sato, Masao Fukumori, Toshiro Motoya
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 3, Iss 1, Pp 1-7 (2017)
Abstract Background As of 2014, community pharmacies in Japan are approved by the Ministry of Health, Labour and Welfare to measure lipid panel, HbA1c, glucose, ALT, AST and γ-GTP, but not to screen for influenza virus. We provided influenza virus s
Externí odkaz:
https://doaj.org/article/df5dc58494d34cedb14ccac2f3995fc4
Autor:
Tomoko Kondo, Yuki Kondo, Yuji Orita, Fumi Mitarai, Yoichi Ishitsuka, Mitsuru Irikura, Yoshihiro Shimodozono, Tsutomu Douchi, Yasuo Takeda, Tetsumi Irie
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0157198 (2016)
This study aimed to evaluate predictive factors involved in efficacy and safety in Japanese infants who received theophylline therapy to prevent apnea of prematurity (AOP) after weaning from mechanical ventilation.We retrospectively reviewed the medi
Externí odkaz:
https://doaj.org/article/7143c14a57544e6594acaab5b88586cf
Autor:
Nobuhiro Ooba, Tsugumichi Sato, Akira Wakana, Takao Orii, Masaki Kitamura, Akira Kokan, Hideaki Kurata, Yoshihiro Shimodozono, Kenichi Matsui, Hiroshi Yoshida, Takuhiro Yamaguchi, Shigeru Kageyama, Kiyoshi Kubota
Publikováno v:
PLoS ONE, Vol 9, Iss 5, p e96919 (2014)
PURPOSE: To assess the association between statins and diverse adverse events in Japanese population. METHODS: New users of statin who started statin after 6-month period of non-use were identified in 68 hospitals between January 2008 and July 2010.
Externí odkaz:
https://doaj.org/article/cc32605692a6492d86746a8fd604cfd6
Autor:
Keizo Sato, Ryuji Ikeda, Junichiro Sonoda, Naoki Yoshikawa, Kenji Ogata, Yoshihiro Shimodozono
Publikováno v:
International journal of clinical pharmacology and therapeutics. 59(3)
Objective To assess the effect of green tea intake on the pharmacokinetics of the β-blocker celiprolol. Materials and method In an open-label crossover study, 3 healthy subjects were given water or a green tea beverage daily for 3 days. On day 4, ea
Autor:
Takashi Furuie, Riku Kawano, Junichiro Sonoda, Masao Fukumori, Takaya Murakami, Mitsuaki Fukumori, Yusuke Sakamoto, Akio Kawachi, Keiko Narumi, Shunya Mouri, Susumu Chiyotanda, Toshiro Motoya, Keizo Sato, Yoshihiro Shimodozono, Kenji Etoh
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences
Journal of Pharmaceutical Health Care and Sciences, Vol 3, Iss 1, Pp 1-7 (2017)
Journal of Pharmaceutical Health Care and Sciences, Vol 3, Iss 1, Pp 1-7 (2017)
Background As of 2014, community pharmacies in Japan are approved by the Ministry of Health, Labour and Welfare to measure lipid panel, HbA1c, glucose, ALT, AST and γ-GTP, but not to screen for influenza virus. We provided influenza virus screening
Autor:
Yuta Yokoyama, Yasuo Takeda, Yoshihiro Shimodozono, Yoshifumi Iguro, Hiroyuki Yamamoto, Norifumi Morikawa, Yoshiro Okano, Yutaka Imoto, Katsushi Yamada, Erika Watanabe, Kazuaki Matsumoto, Shiro Ishida, Kazuro Ikawa
Publikováno v:
Journal of Infection and Chemotherapy. 18:878-882
Surgical site infections are a major cause of postoperative morbidity and mortality in cardiovascular surgery. Proper antibiotic prophylaxis can reduce the rate of such infections, but the concentration of antibiotic must be maintained at an adequate
Autor:
Tetsumi Irie, Yasuo Takeda, Fumi Mitarai, Tsutomu Douchi, Yoshihiro Shimodozono, Yuji Orita, Mitsuru Irikura, Yoichi Ishitsuka, Yuki Kondo, Tomoko Kondo
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 7, p e0157198 (2016)
PLoS ONE, Vol 11, Iss 7, p e0157198 (2016)
Purpose This study aimed to evaluate predictive factors involved in efficacy and safety in Japanese infants who received theophylline therapy to prevent apnea of prematurity (AOP) after weaning from mechanical ventilation. Methods We retrospectively
Autor:
Katsushi Yamada, Yasuo Takeda, Keiko Yaji, Kazuaki Matsumoto, Yoshihiro Shimodozono, Akari Shigemi, Kazuro Ikawa, Norifumi Morikawa
Publikováno v:
International Journal of Antimicrobial Agents. 38:417-420
Liposomal amphotericin B (L-AmB), which was developed to reduce side effects, has been shown to have a better safety profile than both the deoxycholate and lipid complex forms of amphotericin B; however, the frequency of major side effects is still u
Autor:
Akari Shigemi, Keiko Yaji, Norifumi Morikawa, Naoko Kanazawa, Tomohide Fukamizu, Katsushi Yamada, Kazuaki Matsumoto, Kazuro Ikawa, Yasuo Takeda, Yoshihiro Shimodozono
Publikováno v:
Journal of Infection and Chemotherapy. 17:297-300
Teicoplanin is a glycopeptide antibacterial agent that has a long serum half-life and therefore takes time to achieve steady-state conditions. An appropriate initial dosing is needed for teicoplanin to promptly reach an effective serum trough concent
Autor:
Tomohide Fukamizu, Yasuo Takeda, Katsushi Yamada, Yoshihiro Shimodozono, Norifumi Morikawa, Naoko Fukunaga, Kazuaki Matsumoto, Kentaro Nishida, Kazuro Ikawa, Kazuko Abematsu
Publikováno v:
International Journal of Antimicrobial Agents. 34:91-94
Voriconazole metabolism is mostly mediated via the cytochrome P450 (CYP) 2C19 isozyme. The non-wild (mutant) type of CYP2C19 is generally found in 60-70% of Asian populations. Because the voriconazole trough plasma concentration has been reported to